Therapeutic progression of quinazolines as targeted chemotherapeutic agents

被引：92
作者：
Bansal, Ranju [1 ]
Malhotra, Anjleena [1 ]
机构：
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Sect 14, Chandigarh 160014, India
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 211卷
关键词：
Quinazoline; Targeted therapy; Anticancer agents; Protein kinase inhibitors; SAR; BCRP inhibitors; TYROSINE KINASE INHIBITORS; POTENT EGFR INHIBITORS; CYCLIN-DEPENDENT KINASE; AURORA-B KINASE; BIOLOGICAL EVALUATION; IN-VITRO; 4-ANILINOQUINAZOLINE DERIVATIVES; LUNG-CANCER; QUINAZOLINE-2,4(1H,3H)-DIONE DERIVATIVES; PHOSPHATIDYLINOSITOL; 3-KINASE;
D O I：
10.1016/j.ejmech.2020.113016
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Presently cancer is a grave health issue with predominance beyond restrictions. It can affect any organ of the body. Most of the available chemotherapeutic drugs are highly toxic, not much selective and eventually lead to the development of resistance. Therefore, a target specific palliative approach for the treatment of cancer is required. Remarkable advancements in science have illuminated various molecular pathways responsible for cancer. This has resulted in abundant opportunities to develop targeted anticancer agents. Quinazoline nucleus is a privileged scaffold with significant diversified pharmacological activities. Numerous established anticancer quinazoline derivatives constitute a new class of chemotherapeutic agents which are found to act by inhibiting various protein kinases as well as other molecular targets. A recent update on various quinazoline derivatives acting on different types of molecular targets for the treatment of cancer has been compiled in this review. Brief SAR studies of quinazoline derivatives acting through different mechanisms of action have been highlighted. The comprehensive medicinal chemistry aspects of these agents in this review provide a panoramic view to the biologists as well as medicinal chemists working in this area and would assist them in their efforts to design and synthesize novel quinazoline based anticancer compounds. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：30
相关论文
共 189 条
[1]   Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase [J].
Abouzid, Khaled ;
Shouman, Samia .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (16) :7543-7551
[2]   Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and Docking [J].
Ai, Yong ;
Wang, Shao-Teng ;
Sun, Ping-Hua ;
Song, Fa-Jun .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (10) :3705-3724
[3]   Nonclassical antifolates, part 3: Synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones [J].
Al-Omary, Fatmah A. M. ;
Hassan, Ghada S. ;
El-Messery, Shahenda M. ;
Nagi, Mahmoud N. ;
Habib, El-Sayed E. ;
El-Subbagh, Hussein I. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 :33-45
[4]   Non-classical antifolates. Part 2: Synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones [J].
Al-Omary, Fatmah A. M. ;
Abou-zeid, Laila A. ;
Nagi, Mahmoud N. ;
Habib, El-Sayed E. ;
Abdel-Aziz, Alaa A-M. ;
El-Azab, Adel S. ;
Abdel-Hamide, Sami G. ;
Al-Omar, Mohamed A. ;
Al-Obaid, Abdulrahman M. ;
El-Subbagh, Hussein I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (08) :2849-2863
[5]   Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs [J].
Al-Rashood, Sarah T. ;
Aboldahab, Ihsan A. ;
Nagi, Mahmoud N. ;
Abouzeid, Laila A. ;
Abdel-Aziz, Alaa A. M. ;
Abdel-hamide, Sarni G. ;
Youssef, Khairia M. ;
Al-Obaid, Abdulrahman M. ;
EI-Subbagh, Hussein I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) :8608-8621
[6]   Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives [J].
Alafeefy, Ahmed M. ;
Kadi, Adnan A. ;
Al-Deeb, Omar A. ;
El-Tahir, Kamal E. H. ;
Al-jaber, Nabila A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) :4947-4952
[7]   An overview of quinazolines: Pharmacological significance and recent developments [J].
Alagarsamy, V. ;
Chitra, K. ;
Saravanan, G. ;
Solomon, V. Raja ;
Sulthana, M. T. ;
Narendhar, B. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 :628-685
[8]   Role of platelet-derived growth factors in physiology and medicine [J].
Andrae, Johanna ;
Gallini, Radiosa ;
Betsholtz, Christer .
GENES & DEVELOPMENT, 2008, 22 (10) :1276-1312
[9]   Aurora kinases: shining lights on the therapeutic horizon? [J].
Andrews, PD .
ONCOGENE, 2005, 24 (32) :5005-5015
[10]   QUINAZOLINES [J].
ARMAREGO, WLF .
ADVANCES IN HETEROCYCLIC CHEMISTRY, 1963, 1 :253-309
12345678910